Cannabis Law Report

AUGUST 12, 2021

11, 2021 (GLOBE NEWSWIRE) COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2021 and gave an update on recent progress across its business. LONDON, Aug. Conference call.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

The Cannigma

JULY 1, 2022

What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Cannabis is still very much illegal in many countries, which makes it very challenging for researchers to gain access to materials, money, and opportunities to conduct research in the first place.

Research and Development 121

Research and Development Data THC Clinical Trials 121

Cannabis Law Report

SEPTEMBER 25, 2019

It aims to address the state-legal cannabis industry’s lack of access to banking and other financial services. Allowing lawful cannabis companies to access commercial banking services and end their reliance on cash will greatly improve public safety, increase transparency, and promote regulatory compliance.”

Banking 55

Banking Safety Compliance Compliance 55

SpeedWeed

AUGUST 3, 2021

Perhaps unsurprisingly, edibles—which often come in delicious candy or baked good form—are largely to blame, and “legalization may have increased the availability and accessibility of these products to children,” write the authors. They’re not considering access or safety or helping parents keep it away from kids or education.

Edibles 77

Edibles Packaging Education THC 77

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. Upon arrival, expect to present your medical marijuana card and identification for verification. Respect dispensary staff and fellow patients.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. This article analyses media representations of medicinal cannabis in Australian medical publications. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 14, 2019

The health and safety of Nipissing First Nation citizens were the main reasons for the stringent regulations reasons expressed Chief Scott McLeod. That’s where we are working with the province to access that and to circumvent the licensing issue. They are strict. We know that’s not true. We know the truth lies somewhere in the middle.

Legislation 49

Legislation Law Education Access 49

SpeedWeed

APRIL 21, 2021

Georgia’s Access to Medical Cannabis Commission received 70 applications for six production licenses. All of the programs outlined above are “limited license” states – for now – and may present opportunities for those who are patient, have capital, and have connections or partners in those states. . The issues raised are not new.

Programs 52

Programs Dispensary Oil Cultivation 52

Cannabis Law Report

JANUARY 13, 2020

Justin Gover, GW’s Chief Executive Officer expects to discuss these updates as part of a webcast presentation at the 38 th Annual J.P. commercial and government payors to ensure that appropriate patients have access to Epidiolex with as few restrictions as possible. Media Enquiries: Sam Brown Inc. media enquiries.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

DECEMBER 8, 2019

This is particularly important in the United States with respect to the FDA, which has bemoaned a lack of data it can use to create policy and regulations of cannabis products, and in Europe with respect to the Food Safety Division of the European Commission’s application of the Novel Foods designation to cannabidiol (CBD). Agenda Item 5.2.

Medicine 45

Medicine Research and Development Food Cannabinoids 45

Leaf Science

JUNE 28, 2019

We needed to gain validation from each other at a time when mass media was repeatedly saying we were dangerous ‘stupid stoners’. It’s painful to see but it is a lot less painful than the idea of people around the world needing cannabis but not allowed access. Health and safety benefits. All to bring people together.”.

Decriminalization 64

Decriminalization Sleep Access Law 64

Cannabis Law Report

APRIL 8, 2022

The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D., Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JUNE 14, 2019

The whole environment can only be accessed by biometrics. The remedies will have controls like the present ones, which may be just the presentation of revenue to purchase, to the more restrictive sales that need registration and retention of revenue. The proposals made public 11 June may cause friction with central government ?

Medicine 40

Medicine Pharmaceutical Environment Cultivation 40

Cannabis Law Report

SEPTEMBER 17, 2019

Some people blame easy access to semi-automatic weapons. If we want to enact Second Amendment restrictions — as many argue we must in the wake of recent violence — we need to do so in a manner that will truly protect public safety. A Nation That Does Nothing About Gun Violence Has No Business Discriminating Against Cannabis Users.

Patients 45

Patients Marijuana Policy History 45

The Joint Blog

JUNE 19, 2023

This presents a significant opportunity for businesses looking to enter or expand their presence in the CBD pet products space. With a strong commitment to quality, safety, and efficacy, The Emerald Corp has quickly become a trusted partner for businesses looking to offer their customers the best in CBD pet products. from 2020 to 2027.

Pets 29

Pets CBD Research and Development Safety 29

Meadow

DECEMBER 24, 2017

One part of the Type 9 creation that’s important is it’s exempt from the public access provisions. So the concern about having limited access areas, or areas that are only open to employees versus the general public, with Type 9 there’s less of that concern because you’re not open to the general public. Aaron Flynn [00:33:27?—?oftentimes

Packaging 40

Packaging Retail Edibles Wellness and Beauty 40

Canna Law Blog

DECEMBER 19, 2022

Safety and accessibility concerns were at the fore. For on-site delivery or drive-up delivery a new rule has been added that prohibits delivery to a car if minors are present, unless the minors are accompanying a parent or guardian. Maybe even follow the Commission on any of its social media. Proposed OAR 845-025-1300.

Retail 95

Retail Packaging Media Compliance 95

Canna Law Blog

OCTOBER 28, 2021

It is meant to regulate every link in the cannabis production and distribution chains so as to ensure quality and traceability of the products consumers will have access to– whether for medical, industrial or adult purposes. However, the Church’s position has been manipulated by some media outlets.

Edibles 98

Edibles Consumption Media Education 98

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities. Testing for Safety: Are Impurities a Problem?

THC 96

THC CBD Legalization Vaping 96

Alchimia

JANUARY 4, 2016

ve got legitimate access to medicinal cannabis for an approved purpose? Unfortunately, the customs services confiscated his medicine lately in a control realized during the way back home despite presenting the recipe of his doctor and the official roles. The assistant of the health minister, Stephen Jones, stated: ?We t dangerous.

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

SEPTEMBER 19, 2019

Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . The new quarterly release of the Marijuana Business Factbook presents updated profiles of each state market, highlighting the growth occurring in each.

Vaping 55

Vaping Hemp Education Patients 55

The Cannigma

MARCH 2, 2022

Hear the tale of how Anthony came to work in the cannabis space, telling the stories of cannabis brands and making them accessible to non-users. Anthony is the founder of the Trav Media Group. We’ve got a segment with Americans for Safe Access, talking a little bit about regulation and some current affairs. This is a pleasure.

Wellness and Beauty 52

Wellness and Beauty Cannabis Media Patients 52

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. The Essay presents proposals to reduce the risk of biopiracy and the issuance of unwarranted psychedelic patents. 11 × 11. In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Feduccia et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52